Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectis S.A. - American Depositary Shares
(NQ:
CLLS
)
4.300
-0.110 (-2.49%)
Streaming Delayed Price
Updated: 10:21 AM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectis S.A. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
July 28, 2025
From
Cellectis Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 25, 2025
Via
Benzinga
What's going on in today's session
↗
July 25, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 14, 2025
Via
Benzinga
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
June 26, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
May 21, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Reports Financial Results for the First Quarter 2025
May 12, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report First Quarter Financial Results on May 12, 2025
May 06, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
April 28, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
April 22, 2025
Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.
Via
MarketBeat
The market is filled with gapping stocks in Friday's session.
↗
April 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
March 14, 2025
Via
Benzinga
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
March 13, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
March 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Earnings Scheduled For March 13, 2025
↗
March 13, 2025
Via
Benzinga
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
February 24, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)
December 10, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
November 05, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Provides Business Updates and Financial Results for Third Quarter 2024
November 04, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024
October 30, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
October 22, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
September 03, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors
August 26, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer
August 07, 2024
From
Cellectis Inc.
Via
GlobeNewswire
CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Cellectis Provides Financial Results for the Second Quarter 2024
August 06, 2024
From
Cellectis Inc.
Via
GlobeNewswire
FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment
August 01, 2024
From
Cellectis Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
